MYD88 and breast carcinoma: confirmed elevated levels of MyD88 protein in hormone-resistant breast cancer cell lines, MDA-MB-231, MDA-MB-231HM, and MDA-MB-468, compared to MCF-7 and SKBR3 cells (18).